This is the first, brief post based on this morning’s program at Boston’s Seaport Hotel sponsored by National Association of Corporate Directors–New England. (Disclosure: I am on the Advisory Board to, and Secretary of, NACD-New England). At the end of … Continue reading
Category Archives: The Law
The law relating to nonfungible tokens continues to limp along without clear guidance. In the past, the SEC has taken the general position that if you sell an NFT based on the express or implied promise of making a profit … Continue reading
I have previously posted about the issue of whether US copyright protection is available for art or text created by use of artificial intelligence. On August 18, the United States District Court for the District of Columbia denied copyright protection … Continue reading
This post is a recommendation to corporate directors and C-level executives to take a look at the magazine Directorship, which is available to members of the National Association of Corporate Directors. [Alert: I am a member of the New England Chapter … Continue reading
Back from a European holiday and need to catch you up on a few things. Let me start with new regulations of SEC-registered advisers to private equity and hedge funds. In a now-familiar pattern for increased regulation (approval by a … Continue reading
This week the Department of Justice and the Federal Trade Commission released draft guidelines relating to permissible mergers, that is mergers that they will not challenge and attempt to prevent. The guidelines are substantially different from, and materially less favorable … Continue reading
All the above are famous writers. The first two have copyright protection. Writers can copyright their works. What protection does a human writer have who claims protection against copying when a text is generated by GAI on instruction from that … Continue reading
AI has a significant role, and a growing role, in healthcare. AI can apply massive date to improve diagnosis, treatment program design, drug development and robotic surgery. Medical literature doubles every seven years, promising massive updated data to be processed … Continue reading
The FDA has a Task Force with focus on companies subject to FDA regulation/clearances. It should be remembered that while the SEC regulates, and monitors disclosure by, public companies, much of what they do also covers private enterprises which raise … Continue reading
The SEC has a Small Business Capital Formation Advisory Committee (“Committee”) to propose regulation that would make it easier for small business to raise investment capital. A recent survey found that 89% of small businesses feel capital-limited, but only 6% … Continue reading